<unk>  is a bisphosphonate that is FDA approved for the treatment of hypercalcemia of malignancy,  multiple myeloma,  bone metastases of solid tumors,  osteoporosis,paget's disease,  postmenopausal osteoporosis.   Common adverse reactions include nausea,  fatigue, anemia,  bone pain,  constipation,  fever,  vomiting,  dyspnea.
Zoledronic acid
Risedronate
Pamidronic acid
Etidronate
Zoledronate
Tiludronate
Alendronate
Ibandronate 